Scientists have discovered a potential retroviral link to chronic fatigue
syndrome, known as CFS, a debilitating disease that affects millions of people
in the United States and many more women than men. Read Full Article
For years, conventional wisdom held that a substance called amyloid beta, which causes the plaque deposits characteristic of Alzheimer's disease, was the primary cause of the disease. But recent research at Lerner Research Institute has found that the origins of the neurodegenerative disease are more complex -- and that another culprit might share as much, if not more, of the blame. Read Full Article
Cleveland Clinic researchers have found that damage to the blood-brain barrier (BBB) may actually protect lung cancer patients from developing brain metastases. Read Full Article
The Institute has received a five-year, $8.2 million Program Project Grant focused on the persistence of central nervous system infection associated with the loss of the myelin sheath and neuronal function. It is funded by the National Institute of Neurological Disorders and Stroke of the National Institutes of Health. Read Full Article
The National Institutes of Health selected the Lerner Research Institute as one of seven sites at which to launch the first government-sponsored clinical trial to determine what dose of the 2009 H1N1 influenza vaccine is needed to induce a protective immune response in people with asthma, especially those with severe disease. Read Full Article
The Institute recently welcomed Zong-Ming Li, PhD, who focuses on hand biomechanics and upper limb rehabilitation and Matthew Summers, PhD, who studies the regulation of cellular proliferation. Read Full Article
Fifteen Institute researchers recently received new grants totaling more than $16 million. Read Full Article
Lerner Research Institute
Cleveland Clinic, Mail Code NB21
9500 Euclid Avenue
Cleveland, Ohio 44195